Ashwagandha safety findings rely on literature and computer predictions
The analysis favored roots over other plant parts for liver and reproductive toxicity assessments, but it cannot establish clinical safety or supplement effectiveness.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The analysis reported a more favorable liver and reproductive toxicity profile for ashwagandha root than for other plant parts. However, it combined literature review with computer predictions, rather than establishing safety through a clinical trial. Its conclusions cannot confirm that a particular supplement is safe for users or effective for treating any condition.
The abstract provides no clinical event rates, exposure doses or validation results for the prediction models. The authors call for experimental and clinical confirmation, so its favorable assessment should not be read as proof of safety.
What the models contributed
Researchers used language-processing tools to review literature and models that relate molecular structure to predicted toxicity. They paid particular attention to withanolides because the available safety information about these compounds was conflicting.
Case reports complicate attribution
The review also considered reports of liver toxicity. Many involved supplements containing both root and leaf material, making it difficult to determine which plant part was responsible for the reported toxicity.
The original publication
Comprehensive safety evaluation of Withania somnifera (Ashwagandha): an AI-driven meta-analysis and quantitative structure-activity relationship based toxicity assessment.
Ronen Y, Ebert C, Tamim-Yecheskel BC et al.
Front Nutr · 2025
- PubMed ID
- 41368179
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.